Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cep-33457
2. Ipp 201101
3. Chembl3989801
4. P-140
| Molecular Weight | 2699.0 g/mol |
|---|---|
| Molecular Formula | C119H185N34O34PS |
| Hydrogen Bond Donor Count | 38 |
| Hydrogen Bond Acceptor Count | 42 |
| Rotatable Bond Count | 85 |
| Exact Mass | 2698.3284321 g/mol |
| Monoisotopic Mass | 2697.3250773 g/mol |
| Topological Polar Surface Area | 1160 Ų |
| Heavy Atom Count | 189 |
| Formal Charge | 0 |
| Complexity | 5770 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 21 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
19
PharmaCompass offers a list of IPP-201101 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right IPP-201101 manufacturer or IPP-201101 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred IPP-201101 manufacturer or IPP-201101 supplier.
PharmaCompass also assists you with knowing the IPP-201101 API Price utilized in the formulation of products. IPP-201101 API Price is not always fixed or binding as the IPP-201101 Price is obtained through a variety of data sources. The IPP-201101 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A IPP 201101 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of IPP 201101, including repackagers and relabelers. The FDA regulates IPP 201101 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. IPP 201101 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A IPP 201101 supplier is an individual or a company that provides IPP 201101 active pharmaceutical ingredient (API) or IPP 201101 finished formulations upon request. The IPP 201101 suppliers may include IPP 201101 API manufacturers, exporters, distributors and traders.
IPP 201101 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of IPP 201101 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right IPP 201101 GMP manufacturer or IPP 201101 GMP API supplier for your needs.
A IPP 201101 CoA (Certificate of Analysis) is a formal document that attests to IPP 201101's compliance with IPP 201101 specifications and serves as a tool for batch-level quality control.
IPP 201101 CoA mostly includes findings from lab analyses of a specific batch. For each IPP 201101 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
IPP 201101 may be tested according to a variety of international standards, such as European Pharmacopoeia (IPP 201101 EP), IPP 201101 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (IPP 201101 USP).
